Ismael G, Hegg R, Muehlbauer S, et al. Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I—III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial. Lancet. Online 09 August 2012.
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2013 Remedy Health Media, LLC. All Rights Reserved.
Eight Breast Cancer Symptoms: When To Worry 
Ten Breast Cancer Myths Debunked 
Eat to Live: 10 Things to Know About Breast Cancer and Nutrition 
Breast Cancer Survivors: 10 things to guard against 
